Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.
Protein

Thiopurine S-methyltransferase

Gene

TPMT

Organism
Homo sapiens (Human)
Status
Reviewed-Annotation score: Annotation score: 5 out of 5-Experimental evidence at protein leveli

Functioni

Catalyzes the S-methylation of thiopurine drugs such as 6-mercaptopurine.1 Publication

Catalytic activityi

S-adenosyl-L-methionine + a thiopurine = S-adenosyl-L-homocysteine + a thiopurine S-methylether.1 Publication

Enzyme regulationi

Inhibited by S-adenosyl-L-homocysteine (SAH).

Kineticsi

  1. KM=5.6 mM for S-adenosyl-L-methionine1 Publication
  2. KM=0.35 mM for 6-mercaptopurine1 Publication

Vmax=0.6 nmol/sec/mg enzyme toward 6-mercaptopurine (at 37 degrees Celsius)1 Publication

Sites

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Binding sitei40 – 401SubstrateBy similarity
Binding sitei69 – 691S-adenosyl-L-methionine; via carbonyl oxygen
Binding sitei90 – 901S-adenosyl-L-methionine
Binding sitei152 – 1521S-adenosyl-L-methionine

GO - Molecular functioni

  1. thiopurine S-methyltransferase activity Source: ProtInc

GO - Biological processi

  1. methylation Source: Reactome
  2. nucleobase-containing compound metabolic process Source: ProtInc
  3. small molecule metabolic process Source: Reactome
  4. xenobiotic metabolic process Source: Reactome
Complete GO annotation...

Keywords - Molecular functioni

Methyltransferase, Transferase

Keywords - Ligandi

S-adenosyl-L-methionine

Enzyme and pathway databases

BRENDAi2.1.1.67. 2681.
ReactomeiREACT_268027. Defective TPMT causes Thiopurine S-methyltransferase deficiency (TPMT deficiency).
REACT_6946. Methylation.

Names & Taxonomyi

Protein namesi
Recommended name:
Thiopurine S-methyltransferase (EC:2.1.1.67)
Alternative name(s):
Thiopurine methyltransferase
Gene namesi
Name:TPMT
OrganismiHomo sapiens (Human)
Taxonomic identifieri9606 [NCBI]
Taxonomic lineageiEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo
ProteomesiUP000005640 Componenti: Chromosome 6

Organism-specific databases

HGNCiHGNC:12014. TPMT.

Subcellular locationi

GO - Cellular componenti

  1. cytosol Source: Reactome
  2. extracellular vesicular exosome Source: UniProtKB
Complete GO annotation...

Keywords - Cellular componenti

Cytoplasm

Pathology & Biotechi

Involvement in diseasei

Thiopurine S-methyltransferase deficiency (TPMT deficiency)14 Publications

The disease is caused by mutations affecting the gene represented in this entry.

Disease descriptionEnzyme involved in the normal metabolic inactivation of thiopurine drugs. These drugs are generally used as immunosuppressants or cytotoxic drugs and are prescribed for a variety of clinical conditions including leukemia, autoimmune disease and organ transplantation. Patients with intermediate or no TPMT activity are at risk of toxicity after receiving standard doses of thiopurine drugs and it is shown that inter-individual differences in response to these drugs are largely determined by genetic variation at the TPMT locus.

See also OMIM:610460
Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Natural varianti80 – 801A → P in TPMT deficiency; allele TPMT*2; 100-fold reduction in activity; protein shows enhanced degradation; TPMT*2 allele frequency is 0.5%; seems to be restricted to the Caucasian population. 8 Publications
Corresponds to variant rs1800462 [ dbSNP | Ensembl ].
VAR_005637
Natural varianti154 – 1541A → T in TPMT deficiency; allele TPMT*3A and allele TPMT*3B; very low activity; protein shows enhanced degradation leading to strongly reduced protein levels. 13 Publications
Corresponds to variant rs1800460 [ dbSNP | Ensembl ].
VAR_005638
Natural varianti215 – 2151R → H in TPMT deficiency; allele TPMT*8; intermediate activity. 2 Publications
Corresponds to variant rs56161402 [ dbSNP | Ensembl ].
VAR_008715
Natural varianti227 – 2271H → Q in TPMT deficiency; allele TPMT*7; reduced activity. 2 Publications
Corresponds to variant rs72552736 [ dbSNP | Ensembl ].
VAR_005640
Natural varianti240 – 2401Y → C in TPMT deficiency; allele TPMT*3B and allele TPMT*3C; reduced activity; protein shows enhanced degradation. 12 Publications
Corresponds to variant rs1142345 [ dbSNP | Ensembl ].
VAR_005641

Mutagenesis

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Mutagenesisi152 – 1521R → E: Decreases affinity for 6-mercaptopurine. Slightly decreases catalytic activity. 1 Publication

Organism-specific databases

MIMi610460. phenotype.
Orphaneti413687. Azathioprine or 6-mercatopurine toxicity or dose selection.
240863. Cisplatin toxicity.
3315. Thiopurine S-methyltransferase deficiency.
PharmGKBiPA356.

Chemistry

DrugBankiDB00993. Azathioprine.
DB00436. Bendroflumethiazide.
DB01327. Cefazolin.
DB01033. Mercaptopurine.
DB01250. Olsalazine.
DB01021. Trichlormethiazide.

Polymorphism and mutation databases

BioMutaiTPMT.
DMDMi1730006.

PTM / Processingi

Molecule processing

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Chaini1 – 245245Thiopurine S-methyltransferasePRO_0000220102Add
BLAST

Amino acid modifications

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Modified residuei14 – 141Phosphoserine3 Publications
Modified residuei58 – 581N6-acetyllysine1 Publication

Keywords - PTMi

Acetylation, Phosphoprotein

Proteomic databases

MaxQBiP51580.
PaxDbiP51580.
PeptideAtlasiP51580.
PRIDEiP51580.

PTM databases

PhosphoSiteiP51580.

Expressioni

Gene expression databases

BgeeiP51580.
ExpressionAtlasiP51580. baseline and differential.
GenevestigatoriP51580.

Organism-specific databases

HPAiHPA019851.

Interactioni

Subunit structurei

Monomer.1 Publication

Protein-protein interaction databases

BioGridi113025. 2 interactions.

Structurei

Secondary structure

1
245
Legend: HelixTurnBeta strand
Show more details
Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Turni18 – 214Combined sources
Helixi26 – 3510Combined sources
Helixi47 – 5711Combined sources
Beta strandi64 – 674Combined sources
Helixi75 – 817Combined sources
Beta strandi85 – 895Combined sources
Helixi93 – 10210Combined sources
Beta strandi107 – 1115Combined sources
Beta strandi119 – 1235Combined sources
Beta strandi126 – 1338Combined sources
Helixi135 – 1406Combined sources
Beta strandi146 – 1549Combined sources
Turni155 – 1573Combined sources
Helixi160 – 1623Combined sources
Helixi163 – 17210Combined sources
Beta strandi174 – 18613Combined sources
Turni189 – 1913Combined sources
Helixi201 – 2088Combined sources
Turni209 – 2113Combined sources
Beta strandi212 – 22110Combined sources
Helixi225 – 2306Combined sources
Beta strandi236 – 2449Combined sources

3D structure databases

Select the link destinations:
PDBei
RCSB PDBi
PDBji
Links Updated
EntryMethodResolution (Å)ChainPositionsPDBsum
2BZGX-ray1.58A16-245[»]
2H11X-ray1.89A/B17-245[»]
ProteinModelPortaliP51580.
SMRiP51580. Positions 17-245.
ModBaseiSearch...
MobiDBiSearch...

Miscellaneous databases

EvolutionaryTraceiP51580.

Family & Domainsi

Region

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Regioni29 – 4012S-adenosyl-L-methionine bindingAdd
BLAST
Regioni134 – 1352S-adenosyl-L-methionine binding

Sequence similaritiesi

Phylogenomic databases

eggNOGiCOG0500.
GeneTreeiENSGT00390000016823.
HOVERGENiHBG003037.
InParanoidiP51580.
KOiK00569.
OMAiLWCGDFF.
OrthoDBiEOG7H4DWQ.
PhylomeDBiP51580.
TreeFamiTF328951.

Family and domain databases

Gene3Di3.40.50.150. 1 hit.
HAMAPiMF_00812. Thiopur_methtran.
InterProiIPR029063. SAM-dependent_MTases.
IPR025835. Thiopurine_S-MeTrfase.
IPR008854. TPMT.
[Graphical view]
PfamiPF05724. TPMT. 1 hit.
[Graphical view]
PIRSFiPIRSF023956. Thiopurine_S-methyltransferase. 1 hit.
SUPFAMiSSF53335. SSF53335. 1 hit.
PROSITEiPS51585. SAM_MT_TPMT. 1 hit.
[Graphical view]

Sequencei

Sequence statusi: Complete.

P51580-1 [UniParc]FASTAAdd to basket

« Hide

        10         20         30         40         50
MDGTRTSLDI EEYSDTEVQK NQVLTLEEWQ DKWVNGKTAF HQEQGHQLLK
60 70 80 90 100
KHLDTFLKGK SGLRVFFPLC GKAVEMKWFA DRGHSVVGVE ISELGIQEFF
110 120 130 140 150
TEQNLSYSEE PITEIPGTKV FKSSSGNISL YCCSIFDLPR TNIGKFDMIW
160 170 180 190 200
DRGALVAINP GDRKCYADTM FSLLGKKFQY LLCVLSYDPT KHPGPPFYVP
210 220 230 240
HAEIERLFGK ICNIRCLEKV DAFEERHKSW GIDCLFEKLY LLTEK
Length:245
Mass (Da):28,180
Last modified:October 1, 1996 - v1
Checksum:i190E781155B97BB9
GO

Sequence cautioni

The sequence AAB71631.1 differs from that shown. Reason: Erroneous initiation. Curated
The sequence AAB71632.1 differs from that shown. Reason: Erroneous initiation. Curated

Polymorphismi

Individual variation in the toxicity and therapeutic efficacy of thiopurine drugs is associated with a common genetic polymorphism that controls levels of TPMT activity. Genetic polymorphism in the TPMT gene is such that about 90% of Caucasians have high TPMT activity, 10% have intermediate activity and 1 in 300 individuals has low activity. TPMT activity varies among ethnic groups.
TPMT*3A is the most common allele in the Caucasians and American Caucasians; it is the only mutant allele found in the South West Asians; it is not found in the Chinese. TPMT*3C is common in African-Americans and is the only allele in Chinese, Japanese and Taiwanese individuals. This allele is found at a low frequency in the Caucasians. This suggests that TPMT*3C is the oldest mutation, with TPMT*3B being acquired later to form the TPMT*3A allele in the Caucasian and South West Asian populations. TPMT*2 appears to be a more recent allele, which has only been detected in Caucasians to date. These ethnic differences may be important in the clinical use of thiopurine drugs.

Natural variant

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Natural varianti49 – 491L → S Allele TPMT*5; has very low activity when expressed in a heterologous system. 2 Publications
Corresponds to variant rs72552740 [ dbSNP | Ensembl ].
VAR_005636
Natural varianti80 – 801A → P in TPMT deficiency; allele TPMT*2; 100-fold reduction in activity; protein shows enhanced degradation; TPMT*2 allele frequency is 0.5%; seems to be restricted to the Caucasian population. 8 Publications
Corresponds to variant rs1800462 [ dbSNP | Ensembl ].
VAR_005637
Natural varianti154 – 1541A → T in TPMT deficiency; allele TPMT*3A and allele TPMT*3B; very low activity; protein shows enhanced degradation leading to strongly reduced protein levels. 13 Publications
Corresponds to variant rs1800460 [ dbSNP | Ensembl ].
VAR_005638
Natural varianti179 – 1791Q → H.
Corresponds to variant rs6921269 [ dbSNP | Ensembl ].
VAR_052368
Natural varianti180 – 1801Y → F Allele TPMT*6; reduced activity. 2 Publications
Corresponds to variant rs75543815 [ dbSNP | Ensembl ].
VAR_005639
Natural varianti215 – 2151R → H in TPMT deficiency; allele TPMT*8; intermediate activity. 2 Publications
Corresponds to variant rs56161402 [ dbSNP | Ensembl ].
VAR_008715
Natural varianti227 – 2271H → Q in TPMT deficiency; allele TPMT*7; reduced activity. 2 Publications
Corresponds to variant rs72552736 [ dbSNP | Ensembl ].
VAR_005640
Natural varianti240 – 2401Y → C in TPMT deficiency; allele TPMT*3B and allele TPMT*3C; reduced activity; protein shows enhanced degradation. 12 Publications
Corresponds to variant rs1142345 [ dbSNP | Ensembl ].
VAR_005641

Sequence databases

Select the link destinations:
EMBLi
GenBanki
DDBJi
Links Updated
S62904 mRNA. Translation: AAB27277.1.
U12387 mRNA. Translation: AAC50130.1.
U30518
, U30512, U30513, U30514, U30515, U30516, U30517 Genomic DNA. Translation: AAC50368.1.
AF019369
, AF019364, AF019365, AF019366, AF019367, AF019368 Genomic DNA. Translation: AAC51865.1.
U81562 Genomic DNA. Translation: AAB71625.1.
U81563 Genomic DNA. Translation: AAB71626.1.
U81564 Genomic DNA. Translation: AAB71627.1.
U81565 Genomic DNA. Translation: AAB71628.1.
U81566 Genomic DNA. Translation: AAB71629.1.
U81567 Genomic DNA. Translation: AAB71630.1.
U81568 Genomic DNA. Translation: AAB71631.1. Different initiation.
U81569 Genomic DNA. Translation: AAB71632.1. Different initiation.
U81570 Genomic DNA. Translation: AAB71633.1.
U81571 Genomic DNA. Translation: AAB71634.1.
U81572 Genomic DNA. Translation: AAB71635.1.
U81573 Genomic DNA. Translation: AAB71636.1.
AB045146 Genomic DNA. Translation: BAA97037.1.
AL589723 Genomic DNA. Translation: CAH71233.1.
BC009596 mRNA. Translation: AAH09596.1.
AF035426 Genomic DNA. Translation: AAC32289.1.
AF021876 mRNA. Translation: AAB80746.1.
AF021877 mRNA. Translation: AAB80747.1.
CCDSiCCDS4543.1.
PIRiI57946.
RefSeqiNP_000358.1. NM_000367.3.
UniGeneiHs.444319.

Genome annotation databases

EnsembliENST00000309983; ENSP00000312304; ENSG00000137364.
GeneIDi7172.
KEGGihsa:7172.
UCSCiuc003ncm.3. human.

Polymorphism and mutation databases

BioMutaiTPMT.

Keywords - Coding sequence diversityi

Polymorphism

Cross-referencesi

Sequence databases

Select the link destinations:
EMBLi
GenBanki
DDBJi
Links Updated
S62904 mRNA. Translation: AAB27277.1.
U12387 mRNA. Translation: AAC50130.1.
U30518
, U30512, U30513, U30514, U30515, U30516, U30517 Genomic DNA. Translation: AAC50368.1.
AF019369
, AF019364, AF019365, AF019366, AF019367, AF019368 Genomic DNA. Translation: AAC51865.1.
U81562 Genomic DNA. Translation: AAB71625.1.
U81563 Genomic DNA. Translation: AAB71626.1.
U81564 Genomic DNA. Translation: AAB71627.1.
U81565 Genomic DNA. Translation: AAB71628.1.
U81566 Genomic DNA. Translation: AAB71629.1.
U81567 Genomic DNA. Translation: AAB71630.1.
U81568 Genomic DNA. Translation: AAB71631.1. Different initiation.
U81569 Genomic DNA. Translation: AAB71632.1. Different initiation.
U81570 Genomic DNA. Translation: AAB71633.1.
U81571 Genomic DNA. Translation: AAB71634.1.
U81572 Genomic DNA. Translation: AAB71635.1.
U81573 Genomic DNA. Translation: AAB71636.1.
AB045146 Genomic DNA. Translation: BAA97037.1.
AL589723 Genomic DNA. Translation: CAH71233.1.
BC009596 mRNA. Translation: AAH09596.1.
AF035426 Genomic DNA. Translation: AAC32289.1.
AF021876 mRNA. Translation: AAB80746.1.
AF021877 mRNA. Translation: AAB80747.1.
CCDSiCCDS4543.1.
PIRiI57946.
RefSeqiNP_000358.1. NM_000367.3.
UniGeneiHs.444319.

3D structure databases

Select the link destinations:
PDBei
RCSB PDBi
PDBji
Links Updated
EntryMethodResolution (Å)ChainPositionsPDBsum
2BZGX-ray1.58A16-245[»]
2H11X-ray1.89A/B17-245[»]
ProteinModelPortaliP51580.
SMRiP51580. Positions 17-245.
ModBaseiSearch...
MobiDBiSearch...

Protein-protein interaction databases

BioGridi113025. 2 interactions.

Chemistry

BindingDBiP51580.
ChEMBLiCHEMBL2500.
DrugBankiDB00993. Azathioprine.
DB00436. Bendroflumethiazide.
DB01327. Cefazolin.
DB01033. Mercaptopurine.
DB01250. Olsalazine.
DB01021. Trichlormethiazide.

PTM databases

PhosphoSiteiP51580.

Polymorphism and mutation databases

BioMutaiTPMT.
DMDMi1730006.

Proteomic databases

MaxQBiP51580.
PaxDbiP51580.
PeptideAtlasiP51580.
PRIDEiP51580.

Protocols and materials databases

DNASUi7172.
Structural Biology KnowledgebaseSearch...

Genome annotation databases

EnsembliENST00000309983; ENSP00000312304; ENSG00000137364.
GeneIDi7172.
KEGGihsa:7172.
UCSCiuc003ncm.3. human.

Organism-specific databases

CTDi7172.
GeneCardsiGC06M018072.
HGNCiHGNC:12014. TPMT.
HPAiHPA019851.
MIMi187680. gene.
610460. phenotype.
neXtProtiNX_P51580.
Orphaneti413687. Azathioprine or 6-mercatopurine toxicity or dose selection.
240863. Cisplatin toxicity.
3315. Thiopurine S-methyltransferase deficiency.
PharmGKBiPA356.
GenAtlasiSearch...

Phylogenomic databases

eggNOGiCOG0500.
GeneTreeiENSGT00390000016823.
HOVERGENiHBG003037.
InParanoidiP51580.
KOiK00569.
OMAiLWCGDFF.
OrthoDBiEOG7H4DWQ.
PhylomeDBiP51580.
TreeFamiTF328951.

Enzyme and pathway databases

BRENDAi2.1.1.67. 2681.
ReactomeiREACT_268027. Defective TPMT causes Thiopurine S-methyltransferase deficiency (TPMT deficiency).
REACT_6946. Methylation.

Miscellaneous databases

ChiTaRSiTPMT. human.
EvolutionaryTraceiP51580.
GeneWikiiThiopurine_methyltransferase.
GenomeRNAii7172.
NextBioi28108.
PROiP51580.
SOURCEiSearch...

Gene expression databases

BgeeiP51580.
ExpressionAtlasiP51580. baseline and differential.
GenevestigatoriP51580.

Family and domain databases

Gene3Di3.40.50.150. 1 hit.
HAMAPiMF_00812. Thiopur_methtran.
InterProiIPR029063. SAM-dependent_MTases.
IPR025835. Thiopurine_S-MeTrfase.
IPR008854. TPMT.
[Graphical view]
PfamiPF05724. TPMT. 1 hit.
[Graphical view]
PIRSFiPIRSF023956. Thiopurine_S-methyltransferase. 1 hit.
SUPFAMiSSF53335. SSF53335. 1 hit.
PROSITEiPS51585. SAM_MT_TPMT. 1 hit.
[Graphical view]
ProtoNetiSearch...

Publicationsi

« Hide 'large scale' publications
  1. "Human thiopurine methyltransferase: molecular cloning and expression of T84 colon carcinoma cell cDNA."
    Honchel R., Aksoy I.A., Szumlanski C., Wood T.C., Otterness D.M., Wieben E.D., Weinshilboum R.M.
    Mol. Pharmacol. 43:878-887(1993) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE.
    Tissue: Kidney.
  2. "Thiopurine methyltransferase pharmacogenetics. Cloning of human liver cDNA and a processed pseudogene on human chromosome 18q21.1."
    Lee D., Szumlanski C.L., Houtman J., Honchel R., Rojas K., Overhauser J., Weiben E.D., Weinshilboum R.M.
    Drug Metab. Dispos. 23:398-405(1995) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA].
  3. "Thiopurine methyltransferase pharmacogenetics: human gene cloning and characterization of a common polymorphism."
    Szumlanski C., Otterness D., Her C., Lee D., Brandriff B., Kelsell D., Spurr N., Lennard L., Wieben E., Weinshilboum R.M.
    DNA Cell Biol. 15:17-30(1996) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS TPMT DEFICIENCY THR-154 AND CYS-240.
  4. "Promoter and intronic sequences of the human thiopurine S-methyltransferase (TPMT) gene isolated from a human PAC1 genomic library."
    Krynetski E.Y., Fessing M.Y., Yates C.R., Sun D., Schuetz J.D., Evans W.E.
    Pharm. Res. 14:1672-1678(1997) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA].
  5. Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS SER-49 AND PHE-180, VARIANTS TPMT DEFICIENCY THR-154 AND CYS-240.
  6. "Genomic structure of thiopurine S-methyltransferase gene."
    Nakamura Y.
    Submitted (JUN-2000) to the EMBL/GenBank/DDBJ databases
    Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA].
  7. "The DNA sequence and analysis of human chromosome 6."
    Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L., Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D., Andrews T.D.
    , Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V., Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J., Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J., French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M., Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.
    Nature 425:805-811(2003) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
  8. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
    The MGC Project Team
    Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
    Tissue: Bone marrow.
  9. "Detection of known and new mutations in the thiopurine S-methyltransferase gene by single-strand conformation polymorphism analysis."
    Spire-Vayron de la Moureyre C., Debuysere H., Sabbagh N., Marez D., Vinner E., Chevalier E.D., Lo-Guidice J.-M., Broly F.
    Hum. Mutat. 12:177-185(1998) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 210-245, VARIANT TPMT DEFICIENCY GLN-227.
  10. "Structural basis of substrate recognition in thiopurine s-methyltransferase."
    Peng Y., Feng Q., Wilk D., Adjei A.A., Salavaggione O.E., Weinshilboum R.M., Yee V.C.
    Biochemistry 47:6216-6225(2008) [PubMed] [Europe PMC] [Abstract]
    Cited for: CATALYTIC ACTIVITY, FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, MUTAGENESIS OF ARG-152.
  11. Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14, IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
    Tissue: Cervix carcinoma.
  12. "Large-scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography."
    Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D., Zou H., Gu J.
    Proteomics 8:1346-1361(2008) [PubMed] [Europe PMC] [Abstract]
    Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
    Tissue: Liver.
  13. "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions."
    Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K.
    Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract]
    Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14, IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
    Tissue: Leukemic T-cell.
  14. "Lysine acetylation targets protein complexes and co-regulates major cellular functions."
    Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C., Olsen J.V., Mann M.
    Science 325:834-840(2009) [PubMed] [Europe PMC] [Abstract]
    Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-58, IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
  15. Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
  16. "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome."
    Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L., Ye M., Zou H.
    J. Proteomics 96:253-262(2014) [PubMed] [Europe PMC] [Abstract]
    Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14, IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
    Tissue: Liver.
  17. "Structural basis of allele variation of human thiopurine-S-methyltransferase."
    Wu H., Horton J.R., Battaile K., Allali-Hassani A., Martin F., Zeng H., Loppnau P., Vedadi M., Bochkarev A., Plotnikov A.N., Cheng X.
    Proteins 67:198-208(2007) [PubMed] [Europe PMC] [Abstract]
    Cited for: X-RAY CRYSTALLOGRAPHY (1.58 ANGSTROMS) OF 16-245 IN COMPLEX WITH S-ADENOSYL-L-HOMOCYSTEINE, SUBUNIT, CHARACTERIZATION OF VARIANTS TPMT DEFICIENCY THR-154 AND CYS-240.
  18. "A single point mutation leading to loss of catalytic activity in human thiopurine S-methyltransferase."
    Krynetski E.Y., Schuetz J.D., Galpin A.J., Pui C.-H., Relling M.V., Evans W.E.
    Proc. Natl. Acad. Sci. U.S.A. 92:949-953(1995) [PubMed] [Europe PMC] [Abstract]
    Cited for: VARIANT TPMT DEFICIENCY PRO-80.
  19. "Thiopurine S-methyltransferase deficiency: two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in Caucasians."
    Tai H.-L., Krynetski E.Y., Yates C.R., Loennechen T., Fessing M.Y., Krynetskaia N.F., Evans W.E.
    Am. J. Hum. Genet. 58:694-702(1996) [PubMed] [Europe PMC] [Abstract]
    Cited for: VARIANTS TPMT DEFICIENCY THR-154 AND CYS-240.
  20. "Azathioprine-induced severe pancytopenia due to a homozygous two-point mutation of the thiopurine methyltransferase gene in a patient with juvenile HLA-B27-associated spondylarthritis."
    Leipold G., Schuetz E., Haas J.P., Oellerich M.
    Arthritis Rheum. 40:1896-1898(1997) [PubMed] [Europe PMC] [Abstract]
    Cited for: VARIANTS TPMT DEFICIENCY THR-154 AND CYS-240.
  21. "Enhanced proteolysis of thiopurine S-methyltransferase (TPMT) encoded by mutant alleles in humans (TPMT*3A, TPMT*2): mechanisms for the genetic polymorphism of TPMT activity."
    Tai H.-L., Krynetski E.Y., Schuetz E.G., Yanishevski Y., Evans W.E.
    Proc. Natl. Acad. Sci. U.S.A. 94:6444-6449(1997) [PubMed] [Europe PMC] [Abstract]
    Cited for: CHARACTERIZATION OF VARIANTS TPMT DEFICIENCY PRO-80 AND THR-154, MECHANISM FOR THE GENETIC POLYMORPHISM OF TPMT ACTIVITY.
  22. "Thiopurine methyltransferase alleles in British and Ghanaian populations."
    Ameyaw M.-M., Collie-Duguid E.S.R., Powrie R.H., Ofori-Adjei D., McLeod H.L.
    Hum. Mol. Genet. 8:367-370(1999) [PubMed] [Europe PMC] [Abstract]
    Cited for: VARIANTS TPMT DEFICIENCY PRO-80; THR-154 AND CYS-240.
  23. "Polymorphism of the thiopurine S-methyltransferase gene in African-Americans."
    Hon Y.Y., Fessing M.Y., Pui C.-H., Relling M.V., Krynetski E.Y., Evans W.E.
    Hum. Mol. Genet. 8:371-376(1999) [PubMed] [Europe PMC] [Abstract]
    Cited for: VARIANT TPMT DEFICIENCY HIS-215.
  24. "The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations."
    Collie-Duguid E.S.R., Pritchard S.C., Powrie R.H., Sludden J., Collier D.A., Li T., McLeod H.L.
    Pharmacogenetics 9:37-42(1999) [PubMed] [Europe PMC] [Abstract]
    Cited for: VARIANTS TPMT DEFICIENCY PRO-80; THR-154 AND CYS-240, FREQUENCY AND DISTRIBUTION OF ALLELES.
  25. "Genetic analysis of thiopurine methyltransferase polymorphism in a Japanese population."
    Hiratsuka M., Inoue T., Omori F., Agatsuma Y., Mizugaki M.
    Mutat. Res. 448:91-95(2000) [PubMed] [Europe PMC] [Abstract]
    Cited for: VARIANTS TPMT DEFICIENCY PRO-80; THR-154 AND CYS-240, FREQUENCY AND DISTRIBUTION OF ALLELES.
  26. "Thiopurine S-methyltransferase pharmacogenetics: variant allele functional and comparative genomics."
    Salavaggione O.E., Wang L., Wiepert M., Yee V.C., Weinshilboum R.M.
    Pharmacogenet. Genomics 15:801-815(2005) [PubMed] [Europe PMC] [Abstract]
    Cited for: VARIANTS TPMT DEFICIENCY PRO-80; THR-154; HIS-215; GLN-227 AND CYS-240, VARIANTS SER-49 AND PHE-180, CHARACTERIZATION OF VARIANTS TPMT DEFICIENCY PRO-80; THR-154; HIS-215; GLN-227 AND CYS-240, CHARACTERIZATION OF VARIANTS SER-49 AND PHE-180.
  27. "Severe azathioprine-induced myelotoxicity in a kidney transplant patient with thiopurine S-methyltransferase-deficient genotype (TPMT*3A/*3C)."
    Kurzawski M., Dziewanowski K., Ciechanowski K., Drozdzik M.
    Transpl. Int. 18:623-625(2005) [PubMed] [Europe PMC] [Abstract]
    Cited for: VARIANTS TPMT DEFICIENCY THR-154 AND CYS-240.
  28. "Molecular analysis of thiopurine S-methyltransferase alleles in Taiwan aborigines and Taiwanese."
    Lu H.-F., Shih M.-C., Chang Y.-S., Chang J.-Y., Ko Y.-C., Chang S.-J., Chang J.-G.
    J. Clin. Pharm. Ther. 31:93-98(2006) [PubMed] [Europe PMC] [Abstract]
    Cited for: VARIANTS TPMT DEFICIENCY PRO-80; THR-154 AND CYS-240, FREQUENCY AND DISTRIBUTION OF ALLELES.
  29. "Frequency of the thiopurine S-methyltransferase alleles in the ancient genetic population isolate of Sardinia."
    Rossino R., Vincis C., Alves S., Prata M.J., Macis M.D., Nucaro A.L., Schirru E., Congia M.
    J. Clin. Pharm. Ther. 31:283-287(2006) [PubMed] [Europe PMC] [Abstract]
    Cited for: VARIANTS TPMT DEFICIENCY PRO-80; THR-154 AND CYS-240, FREQUENCY AND DISTRIBUTION OF ALLELES.

Entry informationi

Entry nameiTPMT_HUMAN
AccessioniPrimary (citable) accession number: P51580
Secondary accession number(s): O14806
, O15423, O15424, O15425, O15426, O15515, O15548, O43213, Q5VUK6, Q9UBE6, Q9UBT8, Q9UE62
Entry historyi
Integrated into UniProtKB/Swiss-Prot: October 1, 1996
Last sequence update: October 1, 1996
Last modified: April 29, 2015
This is version 155 of the entry and version 1 of the sequence. [Complete history]
Entry statusiReviewed (UniProtKB/Swiss-Prot)
Annotation programChordata Protein Annotation Program
DisclaimerAny medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care.

Miscellaneousi

Miscellaneous

TPMT deficiency inherited by TPMT*2 and TPMT*3A alleles, are the most prevalent mutant TPMT in humans. TPMT deficiency is associated with lower cellular levels of TPMT protein, and the proteins encoded by TPMT*2 and TPMT*3A mutant alleles are degraded more rapidly by an ATP-dependent proteasome-mediated pathway.

Keywords - Technical termi

3D-structure, Complete proteome, Direct protein sequencing, Reference proteome

Documents

  1. Human chromosome 6
    Human chromosome 6: entries, gene names and cross-references to MIM
  2. Human entries with polymorphisms or disease mutations
    List of human entries with polymorphisms or disease mutations
  3. Human polymorphisms and disease mutations
    Index of human polymorphisms and disease mutations
  4. MIM cross-references
    Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot
  5. PDB cross-references
    Index of Protein Data Bank (PDB) cross-references
  6. SIMILARITY comments
    Index of protein domains and families

External Data

Dasty 3

Similar proteinsi

Links to similar proteins from the UniProt Reference Clusters (UniRef) at 100%, 90% and 50% sequence identity:
100%UniRef100 combines identical sequences and sub-fragments with 11 or more residues from any organism into Uniref entry.
90%UniRef90 is built by clustering UniRef100 sequences that have at least 90% sequence identity to, and 80% overlap with, the longest sequence (a.k.a seed sequence).
50%UniRef50 is built by clustering UniRef90 seed sequences that have at least 50% sequence identity to, and 80% overlap with, the longest sequence in the cluster.